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Abstract
Multisite phosphorylation regulates many transcription factors, including the Serum Response 
Factor partner Elk-1. Phosphorylation of the transcriptional activation domain (TAD) of Elk-1 by 
the protein kinase ERK at multiple sites potentiates recruitment of the Mediator transcriptional 
coactivator complex and transcriptional activation, but the roles of individual phosphorylation 
events remained unclear. Using time-resolved nuclear magnetic resonance spectroscopy, we found 
that ERK2 phosphorylation proceeds at markedly different rates at eight TAD sites in vitro, which 
we classified as fast, intermediate and slow. Mutagenesis experiments showed that 
phosphorylation of fast and intermediate sites promoted Mediator interaction and transcriptional 
activation, whereas modification of slow sites counteracted both functions, thereby limiting Elk-1 
output. Progressive Elk-1 phosphorylation thus ensures a self-limiting response to ERK activation, 
which occurs independently of antagonizing phosphatase activity.
Results and Discussion
Multisite protein phosphorylation increases the complexity of functional signaling outputs 
that can be generated from single protein kinase inputs. It can set thresholds for activity, or 
transform graded signals into switch-like responses (1–4). Many transcription factors and 
their interacting regulatory proteins are subject to multisite phosphorylation, which allows 
distinct aspects of protein function, including protein turnover, nuclear import and export, 
and specific protein interactions, to be controlled independently (5). However, in general, the 
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dynamics and functional roles of individual phosphorylation events are incompletely 
understood.
The ternary complex factor (TCF) subfamily of Ets-domain transcription factors, consisting 
of Elk-1, SAP-1, and Net, provides an example of multisite phosphorylation in 
transcriptional activation. TCFs, together with their partner protein SRF, function in many 
biological processes by coupling SRF target genes to mitogen-activated protein kinase 
(MAP kinase) signaling (5). Mitogenic and stress stimuli induce phosphorylation of TCF C-
terminal transcriptional activation domains (TADs) at multiple S/T-P (Ser- or Thr-Pro) 
phosphorylation sequences, of which eight are conserved across the family (Fig. 1A; fig. S1) 
(6–11). Two MAP kinase-docking sites, the D-box and the Phe-Gln-Phe-Pro (FQFP) motif, 
control phosphorylation of these sites (12–15). Multisite phosphorylation triggers 
transcriptional activation by TCFs, facilitating their interaction with the Mediator 
transcriptional co-activator complex (16–19) but the kinetics with which the different sites 
are phosphorylated, and whether they serve distinct functions, remain unclear.
To obtain atomic-resolution insights into phosphorylation of the Elk-1 TAD, we used nuclear 
magnetic resonance (NMR) spectroscopy (20) to monitor its modification by recombinant 
ERK2 in vitro (Fig. 1B; fig. S2A). Time-resolved NMR experiments revealed that each 
phosphorylation proceeded efficiently, but at markedly different rates. Phosphorylation of 
Thr369 and Ser384, which flank the central Phe–Trp (FW) motif implicated in Mediator 
interaction (18), occurred faster than modification of Thr364, Thr354 and Ser390, whereas 
residues Thr418, Ser423 and Thr337 were modified more slowly (Fig. 1C), which we 
confirmed by immunoblotting (Fig. 1D). Chemical shift analysis (Cα, Cβ) showed no stable 
secondary structure elements in unmodified or phosphorylated Elk-1 TAD (fig. S2B).
As a first step towards understanding the basis for the phosphorylation sites' differential 
kinetic behavior, we devised a reaction model based on Michaelis-Menten enzyme kinetics. 
To simplify the mathematical treatment, we grouped Elk-1 sites into three classes: fast 
(Thr369 and Ser384), intermediate (Thr354, Thr364, and Ser390) and slow (Thr337, Thr418, and 
Ser423). We assumed that ERK2 phosphorylation is distributive, that enzymatic rate 
constants (kcat) are similar for all sites, and that the different sites have relative affinities for 
ERK2 modeled by increasing Michaelis-Menten constants (KMFast < KMInt < KMSlow)(Fig. 
2A, fig. S3A, 20). This model, which recapitulated the measured kinetics of in vitro Elk-1 
phosphorylation well (Fig. 2B) predicted that removal of fast or intermediate sites should 
increase the phosphorylation rates of other sites. To test this idea, we analyzed the 
phosphorylation kinetics of Elk-1 TAD mutants in which we substituted all fast or 
intermediate phosphoacceptor residues with alanines (Elk-1F: Thr369➔Ala, Ser384➔Ala; 
Elk-1I: Thr354➔Ala, Thr364➔Ala, and Ser390➔Ala)(Fig. 2A). In the fast site mutant 
Elk-1F, phosphorylation rates of intermediate and slow sites increased, whereas those of the 
fast and slow sites increased in the intermediate-site mutant Elk-1I; in both cases the altered 
kinetics fit well with those predicted by the model (Fig 2B, fig. S3B). Thus, even the fast 
sites are not phosphorylated at the maximum possible rate in the wildtype protein. Moreover, 
phosphorylation of an Elk-1 TAD mutant in which Thr369 and Ser384 were replaced with 
aspartates was similar to Elk-1F, excluding the possibility that fast-site phosphorylation 
primes later modification events (fig. S3B).
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To gain more insight into the factors affecting individual sites' phosphorylation kinetics, we 
assessed the role played by primary sequence. To do this, we exchanged the sequences 
surrounding the fast Thr369 and slow Ser423 sites. This also effectively exchanged their 
reactivities, which suggests that these sites' phosphorylation rates reflect their position 
relative to ERK docking sequences, rather than intrinsic differences in reactivity (Fig. 2C). 
We therefore examined the contributions of the D-box and FQFP ERK docking motifs to 
each site's phosphorylation kinetics. Deletion of the D-box decreased the rates of Thr337, 
Thr354, Thr364 and Thr369 phosphorylation, but increased the rates of Ser390, Thr418, and 
Ser423 modification (Fig. 2D). In contrast, deletion of the FQFP motif decreased the rate of 
Ser384 phosphorylation, but enhanced modification of intermediate sites, including adjacent 
Ser390, with no effect on the C-terminal sites (Fig. 2D). Thus, the ERK docking motifs 
differentially affect each phosphorylation site's competitive behavior. Previous studies 
showed that Elk-1 TAD phosphorylation by JNK and p38 MAP kinase differs from 
phosphorylation by ERK (10, 21–24), and that this reflects differences in their docking 
interactions (12, 14, 15, 25). Indeed, these kinases exhibited site preferences and 
phosphorylation rates that were distinct from that of ERK2 (fig. S3C). Taken together, our 
results show that the different rates of Elk-1 TAD phosphorylation by ERK2 follow a 
competition mechanism that is governed by the position of individual Elk-1 substrate sites 
relative to ERK2 docking interactions.
To test whether the different kinetic classes of Elk-1 TAD phosphorylation sites are 
functionally equivalent, we expressed mouse Elk-1 mutants in fibroblasts derived from TCF-
deficient (Elk1-/-;Elk3δ/δ;Elk4-/-) triple-knockout mouse embryos (TKO MEFs; fig. S4, A-
C). In these cells, immediate-early (IE) gene expression is defective, but expression of wild-
type mouse Elk-1 restored the IE transcriptional activation seen in wild-type MEFs after 
activation of ERK by treatment with TPA (12-O-tetradecanoylphorbol-13-acetate) (fig. 
S4D). As expected, alanine substitutions of fast and/or intermediate sites, or of the FW 
motif, greatly diminished or abolished the ability of Elk-1 to activate TCF-SRF target gene 
transcription after TPA stimulation (Fig. 3A; fig. S4D). Surprisingly, however, mutation of 
the slow sites substantially enhanced Elk-1-mediated activation of TCF-SRF target genes 
(Fig. 3A). Alanine substitutions at individual slow sites also increased Elk-1 activity, with 
Thr418 exhibiting the greatest effect (Fig. 3B, fig. S4, E-G). TCF-SRF signaling is important 
for cellular proliferation (26, 27), and TKO MEFs proliferate more slowly than wildtype 
MEFs. The reconstituted TKO MEFs exhibited enhanced proliferation rates, which 
correlated with the ability of each mutant to promote transcriptional activation (Fig. 3C).
Phosphorylation of Elk-1 promotes transcriptional activation by facilitating its MED23-
dependent interaction with the Mediator complex (16–18). We therefore investigated 
whether the different transcriptional activities of the Elk-1 mutants reflected alterations in 
Mediator binding. We prepared extracts of TKO cells expressing wildtype or mutant Elk-1 
proteins and assessed Elk-1 assocation with Mediator by co-immunoprecipitation of the 
MED23, MED24 and MED16 subunits. Consistent with the transcription experiments, 
Elk-1–Mediator interaction was induced by TPA stimulation and dependent on the FW 
motif; it was abolished by alanine substitutions of fast and intermediate sites, and was 
increased in the slow-site Elk-1 mutant (Fig. 3D). We obtained similar results when we used 
glutathione S-transferase (GST)-Elk-1 TAD proteins to recover Mediator proteins from 
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unstimulated NIH3T3 cell extracts (Fig. 3E). In this assay, ERK2 phosphorylation time-
course experiments showed that Mediator recovery by the wildtype Elk-1 TAD was most 
efficient prior to modifications of the slow sites (fig. S5, A and B). Taken together, these data 
show that according to the sites involved, ERK2 phosphorylation promotes or inhibits 
transcriptional activation by Elk-1, which reflects alterations in Elk-1–Mediator interactions.
Next, we investigated Elk-1 TAD phosphorylation kinetics in vivo. Previous studies were 
unable to distinguish the progressive phosphorylation of fast and slow Elk-1 sites (6). 
However, by incubating cells at 25° C to slow down reactions, we confirmed that 
phosphorylation rates can be ranked in the order Ser384>Thr364>Thr418, and that different 
site classes exhibited a similar competitive behavior, as seen in vitro (fig. S6A). Reasoning 
that phosphorylation of the Elk-1 TAD might be sensitive to kinetic effects at limiting signal 
strengths, we titrated ERK activity using increasing amounts of TPA. This both increased the 
maximal extent of ERK activation and advanced the time at which it occurred (fig. S6B). At 
low TPA concentrations, Elk-1 fast-site (Thr384) and slow-site (Thr418)-site modifications 
accumulated slowly over 1 hour, whereas at a saturating TPA dose they were maximal by 10 
minutes. Both phosphorylations declined at late times, presumably owing to the action of 
Elk-1 phosphatases (Fig. 4A)(6, 28).
Having established that Elk-1 phosphorylation kinetics are tuned by signal strength, we 
investigated their relationship to transcriptional activation. We compared the ability of 
wildtype Elk-1 and the slow-site mutant Elk-1S to activate transcription in response to 
signals of differing strengths. At saturating TPA concentrations, both proteins activated Egr1 
transcription with similar transient kinetics, although Elk-1S was much more active, 
reflecting the loss of the inhibitory sites (Fig. 4, B and C). At limiting TPA doses, however, 
their behaviors were markedly different. Whereas the activity of wildtype Elk-1 was almost 
maximal by 15 minutes, that of Elk-1S increased substantially beyond this time (Fig. 4B), 
resulting in prolonged Egr1 mRNA accumulation (Fig. 4C). Thus, progressive 
phosphorylation of the Elk-1 TAD by a single kinase, ERK, attenuates the transcriptional 
response of Elk-1, shaping it according to the strength and kinetics of ERK activation.
Our results show that phosphorylation of the Elk-1 TAD by a single kinase, ERK, can either 
promote or inhibit Mediator interaction, depending on the sites involved, thereby modulating 
transcriptional activation. Given that the TAD sequences are conserved in the other TCFs, 
our findings may also apply to them. The more rapidly phosphorylated sites are located in 
the substantially conserved central core of the TAD, and are essential for transcriptional 
activation, lying close to the FW hydrophobic motif required for Elk-1–Mediator interaction 
(10, 18). Multisite phosphorylation of these residues might stabilize this interaction, and 
perhaps also set a signaling threshold for it, similar to the way that multisite phosphorylation 
sets a threshold for the Sic1–Cdc4 interaction (29). In contrast, slowly phosphorylated sites 
located N- and C-terminal of the conserved TAD core act negatively. Their phosphorylation 
inhibits Mediator recruitment and limits transcriptional activation (Fig 4D), and may also 
facilitate recruitment of negative regulators of Elk-1 activity. Together these properties 
ensure that ERK phosphorylation of the Elk-1 TAD is self-limiting, whereby 
phosphorylation of slow sites attenuates TCF-SRF target gene expression under conditions 
of strong or sustained ERK signaling (Fig. 4D). Our results challenge the common 
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assumption that multisite modification events act unidirectionally and can only be reversed 
or limited by antagonistic enzymes. Given the prevalence of such events in different 
biological processes, we expect that similar mechanisms may govern other regulatory 
interactions.
Supplementary Materials
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Multisite phosphorylation of Elk-1 TAD.
(A) Linear outline of Elk-1 fast (red), intermediate (blue), and slow (yellow) S/T-P 
phosphorylation sites. Kinase docking motifs are shown in green; the FW residues (purple) 
are essential for Mediator association. (B) NMR analysis of Elk-1 TAD (amino acids 309 to 
429) phosphorylation with recombinant ERK2. Left: 2D 1H-15N NMR spectrum of 
unphosphorylated Elk-1 (black), with phosphorylation-site signals color-coded as in (A). 
Right: overlay of 2D NMR spectra of phosphorylated [grey & color-coded as in (A)] and 
unmodified Elk-1 (black). (C) Time-resolved modification curves of individual Elk-1 sites 
upon phosphorylation with ERK2; error bars denote differences between replicate 
experiments on two independent samples. (D) Time-course Western blot of GST-Elk-1 TAD 
vphosphorylation and phosphorlyation-site-specific antibody detection.
Mylona et al. Page 8









Figure 2. Phosphorylation kinetics of Elk-1 TAD mutants.
(A) Outline of analyzed Elk-1 TAD mutants. Substrate sites were classified as fast (red), 
intermediate (blue) or slow (yellow) for model calculations. (B) Left: comparison of 
averaged measured data points of wild-type Elk-1 TAD fast-, intermediate- and slow-site 
phosphorylation by ERK2 (circles) with calculated rates according to the competitive 
inhibition model (solid lines). Center: fast-site alanine-substituted Elk-1 TAD (Elk-1F); 
dashed lines show wildtype Elk-1 TAD for comparison. Right: intermediate-site alanine-
substituted Elk-1 TAD (Elk-1I); dashed lines show wildtype Elk-1 TAD for comparison. (C) 
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Time-resolved modification curves (right) of the Elk-1 369/423 switch mutant (left). Error 
bars denote differences between replicate experiments on two independent samples. (D) 
Time-resolved modification curves of ERK docking-site mutants Elk-1ΔD-box (left) and 
Elk-1ΔFQFP (right), presented as in (C). Effects of D-box and FQFP site deletions on Elk-1 
TAD phosphorylation rates are summarised below.
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Figure 3. Effects of Elk-1 TAD mutations on TCF target gene expression, cell proliferation and 
Mediator binding.
(A) Quantitative reverse-transcription polymerase chain reaction (qRT-PCR) analysis of TCF 
target gene transcription in reconstituted TKO MEFs. Cells were reconstituted with wild-
type mouse Elk-1 (WT) or fast-site (F), intermediate-site (I), slow-site (S), fast- and 
intermediate-site (FI) or alanine-substituted FW motif (FW) mutants. (B) Effects of 
individual slow-site alanine substitutions on Egr1 expression. In (A) and (B) cells were 
stimulated with 50 ng/ml TPA where indicated. RNA levels are quantified relative to 
GAPDH; data are means ± SEM, n = 3. (C) Proliferation of wild-type and mutant Elk-1 
TKO MEFs. Data are means ± SEM, n = 3. (D) Co-immunoprecipitation of Mediator with 
wildtype or mutant Flag-tagged Elk-1 from NIH3T3 cell extracts. Antibodies to Mediator 
subunits MED23, MED24 and MED16 were used for immunoblotting. (E) Mediator co-
precipitation from unstimulated NIH3T3 cell extracts using wild-type and mutant GST-
tagged Elk-1 TAD proteins with and without prior ERK2 phosphorylation.
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Figure 4. Multisite phosphorylation of Elk-1 shapes the transcriptional response to ERK 
activation.
(A) Kinetics of Elk-1 fast- and slow-site phosphorylation in cells treated with increasing 
concentrations of TPA. (B) Transcription rate of the TCF-SRF target gene Egr1 in TKO 
MEFs expressing wildtype Elk-1 or mutant Elk-1S. Precursor RNA was monitored by qRT-
PCR after stimulation with different concentrations of TPA. Data are mean ± SEM; n=3. (C) 
Kinetics of Egr1 mRNA accumulation in cells as in (B) monitored by qRT-PCR (D) 
Progressive Elk-1 phosphorylation by ERK has both activating (left and center) and 
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inhibitory (right) effects on Mediator recruitment, as suggested by shading densities. A 
strong signal will rapidly reach the attenuated state shown at the right, a weak signal may 
reach this state only if sustained.
Mylona et al. Page 13
Science. Author manuscript; available in PMC 2017 April 14.
 Europe PM
C Funders A
uthor M
anuscripts
 Europe PM
C Funders A
uthor M
anuscripts
